Kendall Capital Partners

Venture Capital

Cambridge-based VC investing in early-to-commercial stage life sciences and healthcare companies; portfolio includes Rejuvenate Bio and EpiBone.

Cambridge, United States · 3+ investments

Early Stage
Growth
Biotech
Diagnostics
Gene Therapy
Healthcare
Life Sciences
Headquarters
Cambridge, United States
Founded
2021
Total Investments
3
Last Investment
Nov 2024

Investment Thesis

Early-to-commercial stage life sciences and healthcare innovations addressing urgent global medical needs including gene therapy, cell therapy, and AI-enabled diagnostics.

Kendall Capital Partners is a Venture Capital firm based in Cambridge, United States. It has made 3 investments in Biotech and Diagnostics.

Investment History

Sign up to view investment history

Create a free account to see deal history, investment amounts, and round details.